These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 2164479

  • 1. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
    Hermitte L, Vialettes B, Naquet P, Atlan C, Payan MJ, Vague P.
    Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
    [Abstract] [Full Text] [Related]

  • 2. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.
    J Immunol; 1996 Oct 15; 157(8):3737-43. PubMed ID: 8871677
    [Abstract] [Full Text] [Related]

  • 3. Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.
    Atlan-Gepner C, Hermitte L, Janand-Delenne B, Naquet P, Vialettes B.
    Diabetes Metab; 1997 Nov 15; 23(5):386-94. PubMed ID: 9416430
    [Abstract] [Full Text] [Related]

  • 4. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
    Pankewycz O, Strom TB, Rubin-Kelley VE.
    Eur J Immunol; 1991 Apr 15; 21(4):873-9. PubMed ID: 1902177
    [Abstract] [Full Text] [Related]

  • 5. In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice.
    Young LH, Peterson LB, Wicker LS, Persechini PM, Young JD.
    J Immunol; 1989 Dec 15; 143(12):3994-9. PubMed ID: 2480383
    [Abstract] [Full Text] [Related]

  • 6. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice.
    Yasunami R, Bach JF.
    Eur J Immunol; 1988 Mar 15; 18(3):481-4. PubMed ID: 2965652
    [Abstract] [Full Text] [Related]

  • 7. Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction.
    Bedossa P, Bendelac A, Bach JF, Carnaud C.
    Eur J Immunol; 1989 Oct 15; 19(10):1947-51. PubMed ID: 2684673
    [Abstract] [Full Text] [Related]

  • 8. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV.
    Cell Immunol; 2005 May 15; 235(1):1-11. PubMed ID: 16122720
    [Abstract] [Full Text] [Related]

  • 9. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F, Yu M, Zhu Q.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep 15; 34(5):281-3. PubMed ID: 11372396
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
    Kaminitz A, Mizrahi K, Yaniv I, Stein J, Askenasy N.
    J Autoimmun; 2010 Sep 15; 35(2):145-52. PubMed ID: 20638242
    [Abstract] [Full Text] [Related]

  • 11. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
    Martignat L, Feve B, Charbonnel B, Sai P.
    Diabete Metab; 1993 Sep 15; 19(6):566-74. PubMed ID: 8026608
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
    Pacheco-Silva A, Bastos MG, Muggia RA, Pankewycz O, Nichols J, Murphy JR, Strom TB, Rubin-Kelley VE.
    Eur J Immunol; 1992 Mar 15; 22(3):697-702. PubMed ID: 1547815
    [Abstract] [Full Text] [Related]

  • 13. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
    Füchtenbusch M, Larger E, Thebault K, Boitard C.
    Horm Metab Res; 2005 Feb 15; 37(2):63-7. PubMed ID: 15778920
    [Abstract] [Full Text] [Related]

  • 14. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
    Jaakkola I, Jalkanen S, Hänninen A.
    Eur J Immunol; 2003 Dec 15; 33(12):3255-64. PubMed ID: 14635033
    [Abstract] [Full Text] [Related]

  • 15. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor.
    Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni P.
    Eur J Immunol; 1994 Aug 15; 24(8):1843-7. PubMed ID: 8056041
    [Abstract] [Full Text] [Related]

  • 16. Dietary protection against diabetes in NOD mice: lack of a major change in the immune system.
    Hermitte L, Atlan-Gepner C, Payan MJ, Mehelleb M, Vialettes B.
    Diabete Metab; 1995 Oct 15; 21(4):261-8. PubMed ID: 8529761
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.
    J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077
    [Abstract] [Full Text] [Related]

  • 18. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
    McInerney MF, Flynn JC, Goldblatt PJ, Najjar SM, Sherwin RS, Janeway CA.
    J Immunol; 1996 Oct 15; 157(8):3716-26. PubMed ID: 8871675
    [Abstract] [Full Text] [Related]

  • 19. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
    Nishimoto H, Kikutani H, Yamamura K, Kishimoto T.
    Nature; 1996 Oct 15; 328(6129):432-4. PubMed ID: 3302721
    [Abstract] [Full Text] [Related]

  • 20. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.